Antibody-Dependent, FcγRI-Mediated Neutralization of HIV-1 in TZM-bl Cells Occurs Independently of Phagocytosis
暂无分享,去创建一个
[1] S. Zolla-Pazner,et al. Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals. , 2012, Virology.
[2] T. Kepler,et al. Isolation of a Human Anti-HIV gp41 Membrane Proximal Region Neutralizing Antibody by Antigen-Specific Single B Cell Sorting , 2011, PloS one.
[3] Jamie K. Scott,et al. Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies , 2011, Journal of Virology.
[4] H. Ding,et al. Replication competent molecular clones of HIV-1 expressing Renilla luciferase facilitate the analysis of antibody inhibition in PBMC. , 2010, Virology.
[5] D. Irvine,et al. A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples. , 2010, Journal of immunological methods.
[6] Adam D Hoppe,et al. Coordination of Fc receptor signaling regulates cellular commitment to phagocytosis , 2010, Proceedings of the National Academy of Sciences.
[7] D. Burton,et al. Broadly Neutralizing Monoclonal Antibodies 2F5 and 4E10 Directed against the Human Immunodeficiency Virus Type 1 gp41 Membrane-Proximal External Region Protect against Mucosal Challenge by Simian-Human Immunodeficiency Virus SHIVBa-L , 2009, Journal of Virology.
[8] A. Bergamaschi,et al. The CDK Inhibitor p21Cip1/WAF1 Is Induced by FcγR Activation and Restricts the Replication of Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses in Human Macrophages , 2009, Journal of Virology.
[9] B. Haynes,et al. Utilization of Immunoglobulin G Fc Receptors by Human Immunodeficiency Virus Type 1: a Specific Role for Antibodies against the Membrane-Proximal External Region of gp41 , 2009, Journal of Virology.
[10] P. Cresswell,et al. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells , 2009, Proceedings of the National Academy of Sciences.
[11] S. Zolla-Pazner,et al. Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1. , 2009, Molecular immunology.
[12] K. Ravichandran,et al. Phagosome maturation: going through the acid test , 2008, Nature Reviews Molecular Cell Biology.
[13] C. Bewley,et al. Sequestering of the Prehairpin Intermediate of gp41 by Peptide N36Mut(e,g) Potentiates the Human Immunodeficiency Virus Type 1 Neutralizing Activity of Monoclonal Antibodies Directed against the N-Terminal Helical Repeat of gp41 , 2008, Journal of Virology.
[14] Yifan Cheng,et al. A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies , 2008, Proceedings of the National Academy of Sciences.
[15] S. Zolla-Pazner,et al. Cross-Clade Neutralizing Activity of Human Anti-V3 Monoclonal Antibodies Derived from the Cells of Individuals Infected with Non-B Clades of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[16] S. Zolla-Pazner,et al. Nonneutralizing Antibodies Are Able To Inhibit Human Immunodeficiency Virus Type 1 Replication in Macrophages and Immature Dendritic Cells , 2006, Journal of Virology.
[17] S. Zolla-Pazner,et al. Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation. , 2006, Blood.
[18] H. Katinger,et al. The Long Third Complementarity-Determining Region of the Heavy Chain Is Important in the Activity of the Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2F5 , 2004, Journal of Virology.
[19] Christoph Grundner,et al. Access of Antibody Molecules to the Conserved Coreceptor Binding Site on Glycoprotein gp120 Is Sterically Restricted on Primary Human Immunodeficiency Virus Type 1 , 2003, Journal of Virology.
[20] Abraham Pinter,et al. Human Monoclonal Antibodies Specific for Conformation-Sensitive Epitopes of V3 Neutralize Human Immunodeficiency Virus Type 1 Primary Isolates from Various Clades , 2002, Journal of Virology.
[21] S. Zolla-Pazner,et al. Characterization of human monoclonal antibodies selected with a hypervariable loop-deleted recombinant HIV-1(IIIB) gp120. , 2001, Immunology letters.
[22] C. Guzmán-Verri,et al. GTPases of the Rho Subfamily Are Required for Brucella abortus Internalization in Nonprofessional Phagocytes , 2001, The Journal of Biological Chemistry.
[23] S. Zolla-Pazner,et al. Conserved and Exposed Epitopes on Intact, Native, Primary Human Immunodeficiency Virus Type 1 Virions of Group M , 2000, Journal of Virology.
[24] S. Zolla-Pazner,et al. Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins. , 2000, Virology.
[25] S. Zolla-Pazner,et al. Mapping of Epitopes Exposed on Intact Human Immunodeficiency Virus Type 1 (HIV-1) Virions: a New Strategy for Studying the Immunologic Relatedness of HIV-1 , 1998, Journal of Virology.
[26] J. Sodroski,et al. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.
[27] J. Mascola,et al. Serotyping of primary human immunodeficiency virus type 1 isolates from diverse geographic locations by flow cytometry , 1995, Journal of virology.
[28] J. Sodroski,et al. Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1 , 1994, Journal of virology.
[29] M. Kamoun,et al. Transfection of an Fc gamma receptor cDNA induces T cells to become phagocytic. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[30] P. Berman,et al. Cryptic nature of envelope V3 region epitopes protects primary monocytotropic human immunodeficiency virus type 1 from antibody neutralization , 1994, Journal of virology.
[31] S. Zolla-Pazner,et al. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. , 1993, Journal of immunology.
[32] A. Levinson,et al. Human Fc gamma RII, in the absence of other Fc gamma receptors, mediates a phagocytic signal. , 1991, The Journal of clinical investigation.
[33] Y. Moriyama,et al. Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. , 1991, The Journal of biological chemistry.
[34] S. Zolla-Pazner,et al. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies , 1991, Journal of virology.
[35] S. Zolla-Pazner,et al. Generation of human monoclonal antibodies to human immunodeficiency virus. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Sansonetti,et al. Entry of Shigella flexneri into HeLa cells: evidence for directed phagocytosis involving actin polymerization and myosin accumulation , 1987, Infection and immunity.
[37] Y. Matsuzawa,et al. Inhibition of lysosomal phospholipase A and phospholipase C by chloroquine and 4,4'-bis(diethylaminoethoxy) alpha, beta-diethyldiphenylethane. , 1980, The Journal of biological chemistry.
[38] B Poole,et al. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[39] G. Byrne,et al. Parasite-specified phagocytosis of Chlamydia psittaci and Chlamydia trachomatis by L and HeLa cells , 1978, Infection and immunity.
[40] A. Levinson,et al. Human FcYRII , in the Absence of Other Fcl , Receptors , Mediates a Phagocytic Signal , 2013 .
[41] J. Ravetch,et al. Fcγ receptors as regulators of immune responses , 2008, Nature Reviews Immunology.
[42] J. Ravetch,et al. Fcgamma receptors: old friends and new family members. , 2006, Immunity.
[43] D. Montefiori. Role of complement and Fc receptors in the pathogenesis of HIV-1 infection , 2004, Springer Seminars in Immunopathology.